Six-part webinar series with independent faculty on surrogate endpoints in glomerular disease.
Budget vs actual spend
$164k
of $290k planned (57%)
Spend is in line with or behind elapsed time. Elapsed: 70%.
Late-by counts days between due date and completion, or due date and today for open milestones.
| Milestone | Due | Completed | Status | Timing | Late by | Evidence |
|---|---|---|---|---|---|---|
| Webinar series 1–3 | 30 Jun 2026 | 24 Jun 2026 | Completed | Completed on time | — | Mean knowledge gain +22 points |
| Webinar series 4–6 | 30 Nov 2026 | — | In progress | Upcoming | — | — |
Insights routed to this initiative.
eGFR slope interpretation: interest in collaboration reported by academic nephrologist (GB).
Unmet medical need · 01 Aug 2026
Switching between CGRP agents: recurring question reported by primary care physician (IT).
Adherence and persistence · 11 May 2026
Drug interactions: practice variation observed reported by headache specialist (JP).
Adherence and persistence · 18 Apr 2026
Treatment burden and fatigue: interest in collaboration reported by community nephrologist (DE).
Access and reimbursement · 14 Apr 2026
Steroid-sparing strategies: request for data reported by community nephrologist (US).
Patient experience · 28 Feb 2026
Sequencing after progression: gap in current materials reported by pathologist (DE).
Competitor activity · 17 Jan 2026
Comparator checkpoint monotherapy: gap in current materials reported by thoracic medical oncologist (IT).
Efficacy · 16 Jan 2026
Actions whose result record is this initiative.
No actions reference this initiative as their result.
Nothing is linked.
Same objective (SO-NPH-01)
Same objective (SO-NPH-01)
Same objective (SO-NPH-01)
No tasks are linked to this initiative
No audit events for this record
Audit events are written when the record is created, changed, approved, signed or exported.
Data lineage